The estimated Net Worth of Mark J. Day is at least $12.8 Milion dollars as of 4 March 2024. Mr. Day owns over 3,248 units of iRhythm Technologies Inc stock worth over $4,576,902 and over the last 5 years he sold IRTC stock worth over $6,786,210. In addition, he makes $1,436,380 as Executive Vice President of Research and Development at iRhythm Technologies Inc.
Sign up
Mr. Day IRTC stock SEC Form 4 insiders trading
Mark has made over 12 trades of the iRhythm Technologies Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,248 units of IRTC stock worth $360,983 on 4 March 2024.
The largest trade he's ever made was selling 17,500 units of iRhythm Technologies Inc stock on 1 October 2020 worth over $4,027,975. On average, Mark trades about 3,224 units every 90 days since 2019. As of 4 March 2024 he still owns at least 61,164 units of iRhythm Technologies Inc stock.
You can see the complete history of Mr. Day stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mark Day biography
Dr. Mark J. Day Ph.D. serves as Executive Vice President of Research and Development of the Company. He has served as our Executive Vice President of Research & Development since 2012 and has had other leadership roles in Research & Development and systems development since joining the Company in 2007. Previously he worked in Medtronic’s Cardiac Rhythm Disease Management division. Prior to that, Mr. Day was Chief Technical Officer of CarePages, Inc., a blogging site for patients. Mr. Day has an M.B.A. in Marketing from the Wharton School, University of Pennsylvania, a Ph.D. in Computation Flow Physics from Stanford University, and also received an M.S. from Stanford, and a B.Sc. from Queen’s University, both in Mechanical Engineering.
What is the salary of Mark Day?
As the Executive Vice President of Research and Development of iRhythm Technologies Inc, the total compensation of Mark Day at iRhythm Technologies Inc is $1,436,380. There are 2 executives at iRhythm Technologies Inc getting paid more, with Kevin King having the highest compensation of $4,774,140.
How old is Mark Day?
Mark Day is 49, he's been the Executive Vice President of Research and Development of iRhythm Technologies Inc since 2012. There are 19 older and 4 younger executives at iRhythm Technologies Inc. The oldest executive at iRhythm Technologies Inc is Ralph Snyderman, 80, who is the Independent Director.
What's Mark Day's mailing address?
Mark's mailing address filed with the SEC is C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO, CA, 94103.
Insiders trading at iRhythm Technologies Inc
Over the last 8 years, insiders at iRhythm Technologies Inc have traded over $124,847,276 worth of iRhythm Technologies Inc stock and bought 150,000 units worth $2,550,000 . The most active insiders traders include Holdings A/S Novo, Vijay K Lathi a Kevin M King. On average, iRhythm Technologies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $1,872,546. The most recent stock trade was executed by Brice Bobzien on 9 August 2024, trading 1,372 units of IRTC stock currently worth $96,506.
What does iRhythm Technologies Inc do?
irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
What does iRhythm Technologies Inc's logo look like?
Complete history of Mr. Day stock trades at iRhythm Technologies Inc
iRhythm Technologies Inc executives and stock owners
iRhythm Technologies Inc executives and other stock owners filed with the SEC include:
-
Kevin King,
President, Chief Executive Officer, Director -
David Vort,
Executive Vice President - Sales -
Mark Day,
Executive Vice President of Research and Development -
Kevin M. King,
Consultant & Director -
Matthew C. Garrett,
Advisor -
Daniel G. Wilson,
Exec. VP of Strategy, Corp. Devel. & Investor Relations -
Douglas J. Devine,
COO, CFO & Sec. -
David A. Vort,
Exec. VP of Sales & Chief Commercial Officer -
Mark J. Day Ph.D.,
Exec. VP of R&D -
Abhijit Talwalkar,
Independent Chairman of the Board -
Mark Rubash,
Independent Director -
Raymond Scott,
Independent Director -
Bruce Bodaken,
Independent Director -
Ralph Snyderman,
Independent Director -
Cathleen Noel Merz,
Independent Director -
Douglas Devine,
Chief Financial Officer -
Renee Budig,
Independent Director -
Mazi Kiani,
Sr. VP of Quality & Regulatory -
Dietra N. Jones,
Exec. VP of Clinical Operations -
Reyna M. Fernandez,
Exec. VP & Chief HR Officer -
Dr. Mintu P. Turakhia M.D.,
Chief Medical Officer & Chief Scientific Officer -
Allan B. Wilsker,
Exec. VP of Information Technology & Customer Service -
Patrick Michael Murphy J.D.,
Gen. Counsel -
Quentin S. Blackford,
Pres & CEO -
Judith C. Lenane,
Chief Clinical Officer & Exec. VP of Operations -
Kaja J. Odegard,
VP of HR -
Marga Ortigas-Wedekind,
Exec. VP of Marketing -
Michael J. Coyle,
Pres, CEO & Director -
Tiba Aynechi,
Director -
Life Science Partners L P S...,
-
Venture Partners Xi, Lp Cro...,
-
Matthew C. Garrett,
Chief Financial Officer -
Life Science Partners L P S...,
-
Holdings A/S Novo,
10% owner -
Clercq Casper L. De,
Director -
Michael J Coyle,
President and CEO -
Vijay K Lathi,
Director -
Karim Karti,
Former Chief Operating Officer -
Derrick Sung,
EVP, Strat Corp Development -
Mojdeh Poul,
Director -
Brian B Yoor,
Director -
Karen Ling,
Director -
Mervin Smith,
EVP Strategic Business Ops -
Marc W. Rosenbaum,
Chief Accounting Officer -
Daniel G. Wilson,
EVP, Corp Dev Inv Rel -
Brice Bobzien,
Chief Financial Officer -
Quentin S. Blackford,
President and CEO -
Minang Turakhia,
EVP, CMO & CSO -
Reyna M Fernandez,
EVP, Chief HR Officer -
Chad Patterson,
Chief Commercial Officer -
Sumi Shrishrimal,
EVP, Chief Risk Officer -
Patrick Michael Murphy,
CBO and CLO